The journey to parenthood is deeply personal, often filled with hope, anticipation, and sometimes challenges. In Malaysia, the landscape of family planning is evolving, with fertility rates reflecting a significant national concern. Malaysia’s fertility rate for 2024 stood at 1.91, marking a 0.73% decline from 2023. This continuous downward trend underscores the growing need for effective and advanced fertility solutions to help couples achieve their dreams of parenthood. Amidst this backdrop, TMC Fertility, a leader in reproductive medicine, is pioneering a new era of personalised In-Vitro Fertilisation (IVF) by integrating the revolutionary ORA™ (Optimal Receptivity Analysis) test, a game-changer for couples navigating complex fertility journeys.
A New Era of Personalised IVF at TMC Fertility Amidst Declining Fertility Rates
For many couples, IVF represents the most promising path to conceiving. However, even with healthy embryos, the crucial step of implantation into the uterine lining can be a significant hurdle. This delicate process relies on perfect synchrony between the embryo and the uterus’s readiness. Recognising this critical challenge, TMC Fertility has embarked on a groundbreaking strategic partnership with Inti Labs, the innovators behind the world’s first non-invasive ORA™ Endometrial Receptivity Test.
Supporting PDF file: https://intilabs.com/files/uploads/ora-brochure-en-1747197019.pdf
This collaboration is set to transform fertility treatment in Malaysia, promising to “significantly boost IVF success rates and offer patients a more personalised and effective path to parenthood,” as highlighted by TMC Fertility’s commitment. By providing an unprecedented level of precision in embryo transfer timing, TMC Fertility continues to uphold its mission of delivering cutting-edge, patient-centric fertility solutions.
How ORA™ Helps Boosting IVF Success Rates
The integration of the ORA™ test into TMC Fertility’s treatment protocols offers several significant advantages, fundamentally “transforming fertility outcomes” for patients:
- Precision in Timing: ORA™ precisely identifies each patient’s unique optimal window of implantation (WOI). This eliminates guesswork, ensuring the embryo transfer occurs when the uterine lining is most receptive, directly “maximising the chances of successful implantation and pregnancy.”
- Significantly Boosted IVF Success Rates: By aligning the embryo transfer with the individualised WOI, ORA™ dramatically improves the likelihood of successful implantation. This is particularly crucial for patients with a history of repeated implantation failure (RIF), offering them renewed hope and a higher probability of success.
- Non-Invasive and Comfortable: The use of a simple blood sample instead of an invasive endometrial biopsy greatly enhances the patient experience. This reduces physical discomfort, stress, and allows for easier repeat testing if needed.
- Cost and Time Efficiency: By optimising the first embryo transfer attempt, ORA™ can potentially reduce the number of IVF cycles needed, thereby saving significant emotional and financial resources for couples.
- Personalised Treatment: ORA™ allows TMC Fertility specialists to “tailor our approach for each woman, enhancing their chances for a successful pregnancy.” This move towards truly personalised medicine ensures that each patient receives a treatment plan optimised for their unique physiological profile.
- High Accuracy and Reliability: With over 95% accuracy in predicting endometrial receptivity, ORA™ provides reliable and trustworthy information, empowering both patients and clinicians with confidence in treatment decisions.
Looking for fertility medical centres now?
Contact 365Care today to schedule a consultation with specialists from Thomson Hospital and learn more about this cutting-edge solution.For inquiries or to book an appointment, please reach out to 365Care via WhatsApp: +65-90991662.
Resources:
- The Star | Boosting IVF success with innovation, https://www.thestar.com.my/lifestyle/health/2024/10/17/boosting-ivf-success-with-innovation
- Intilabs, https://intilabs.com/ora
- ORA brochure, https://intilabs.com/files/uploads/ora-brochure-report-1730960846.pdf
- National Library of Medicine | In Vitro Fertilization, https://www.ncbi.nlm.nih.gov/books/NBK562266/
Disclaimer: 365Asia aims to provide accurate and up-to-date information, our contents do not constitute medical or any professional advice. If medical advice is required, please consult a licensed healthcare professional. Patient stories are for general reading. They are based on third-party information and have not been independently verified.